Ann: Appendix 2A, page-16

The options were free , 1 free option for every 2 shares bought at 1.1c in the rights issue ,
(exercise price $0.02 expiring 18 months from issue)

RENOUNCEABLE RIGHTS ISSUE

On 8 May 2019 Anteo Diagnostics Limited (Company) announced a renounceable pro rata offer of approximately 232 million fully paid ordinaryshares (New Shares) at an issue price of $0.011 per New Share,
with 1 attaching option (exercise price $0.02 expiring 18 months from issue) for every 2 New Share issued (Rights Issue).

CPS CAPITAL NO 3 PTY LTD ended up with 8,700,000 free options or 4.457%

The Rights Issue is offered on the basis of 1 New Share for every 5 Shares held as at 7:00pm (EST) on 13 May 2019 (Record Date) by shareholders with a registered address in Australia or New Zealand, and will raise up to approximately $2.55 million (before costs).

The Rights Issue is partially underwritten by CPS Capital Group Pty Limited for $1 million. The Directors intend to apply the proceeds from the Rights Issue together with existing cash on hand and expected funds received under an R&D grant as follows: